NewGenIvf Group (NIVF) Competitors $1.79 -0.19 (-9.60%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. ACON, BACK, BTTX, UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, and PIIIWShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Aclarion (ACON), IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Its Competitors Aclarion IMAC Better Therapeutics UpHealth Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners NewGenIvf Group (NASDAQ:NIVF) and Aclarion (NASDAQ:ACON) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, community ranking, earnings, risk, media sentiment, analyst recommendations and institutional ownership. Do institutionals and insiders believe in NIVF or ACON? 66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 7.5% of Aclarion shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by company insiders. Comparatively, 0.8% of Aclarion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, NIVF or ACON? NewGenIvf Group has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNewGenIvf Group$5.43M0.17$130KN/AN/AAclarion$54.60K78.98-$4.91MN/AN/A Does the media prefer NIVF or ACON? In the previous week, NewGenIvf Group and NewGenIvf Group both had 2 articles in the media. Aclarion's average media sentiment score of 1.43 beat NewGenIvf Group's score of 1.23 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment NewGenIvf Group Positive Aclarion Positive Does the MarketBeat Community prefer NIVF or ACON? Aclarion received 4 more outperform votes than NewGenIvf Group when rated by MarketBeat users. CompanyUnderperformOutperformNewGenIvf GroupN/AN/AAclarionOutperform Votes457.14% Underperform Votes342.86% Which has more risk and volatility, NIVF or ACON? NewGenIvf Group has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500. Comparatively, Aclarion has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Do analysts rate NIVF or ACON? Aclarion has a consensus target price of $11,758.50, indicating a potential upside of 158,584.21%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aclarion 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NIVF or ACON more profitable? NewGenIvf Group has a net margin of 0.00% compared to Aclarion's net margin of -12,845.05%. NewGenIvf Group's return on equity of 0.00% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets NewGenIvf GroupN/A N/A N/A Aclarion -12,845.05%-422.87%-201.15% SummaryNewGenIvf Group beats Aclarion on 7 of the 13 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04M$2.01B$5.61B$8.62BDividend YieldN/A7.21%5.28%4.17%P/E RatioN/A16.1727.1419.96Price / Sales0.174.52411.83157.63Price / Cash3.119.3238.2534.64Price / Book0.823.967.064.69Net Income$130K$87.49M$3.23B$248.14M7 Day Performance-22.17%3.80%2.67%2.39%1 Month Performance-43.89%-1.71%8.82%6.05%1 Year Performance-99.21%-16.44%31.44%13.60% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group2.1897 of 5 stars$1.79-9.6%N/A-99.1%$1.04M$5.43M0.00N/ANews CoveragePositive NewsHigh Trading VolumeACONAclarion2.5004 of 5 stars$7.13+3.8%$11,758.50+164,815.8%-99.7%$4.00M$54.60K0.007Positive NewsShort Interest ↓BACKIMACN/A$0.04+8.5%N/A-98.1%$92K$72.05K0.00180Gap UpBTTXBetter TherapeuticsN/A$0.00flatN/A-98.9%$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-100.0%$4K$130M0.001,750ACONWAclarionN/A$0.04-0.3%N/A+16.7%$0.00$54.60K0.007Positive NewsGap UpAONCAmerican Oncology NetworkN/A$11.46+6.1%N/A+653.4%$0.00$1.34B0.001,520High Trading VolumeDHACWDigital Health AcquisitionN/A$0.05flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$23.46+0.7%N/A+6.0%$0.00$234.01M0.00230Positive NewsShort Interest ↓Gap UpOTRKPOntrakN/A$0.24+8.5%N/A-31.5%$0.00$10.84M0.00250Gap UpPIIIWP3 Health PartnersN/A$0.01-1.9%N/AN/A$0.00$1.49B0.00500Gap Down Related Companies and Tools Related Companies Aclarion Alternatives IMAC Alternatives Better Therapeutics Alternatives UpHealth Alternatives Aclarion Alternatives American Oncology Network Alternatives Digital Health Acquisition Alternatives LifeMD Alternatives Ontrak Alternatives P3 Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.